Comparison of transplant efficiency between spontaneously derived and noggin-primed human embryonic stem cell neural precursors in the quinolinic acid rat model of Huntington's disease

Cell Transplantation

Volumn 19, Issue 8, 2010, Pages 1055-1062

  Vazey, Elena M ^a   Dottori, Mirella ^b   Jamshidi, Pegah ^c   Tomas, Doris ^b   Pera, Martin F ^d   Horne, Malcolm ^b,c   Connor, Bronwen ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Huntington's disease; Neural progenitors; Noggin; Stem cell transplantation

Indexed keywords

CYCLOSPORIN; NOGGIN; QUINOLINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CORPUS STRIATUM; EMBRYONIC STEM CELL; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; IN VITRO STUDY; IN VIVO STUDY; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; STEM CELL TRANSPLANTATION;

ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL SURVIVAL; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; HUMANS; HUNTINGTON DISEASE; MALE; NEURAL STEM CELLS; NEURONS; QUINOLINIC ACID; RATS; RATS, WISTAR;

RATTUS;

EID: 78349259276     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X494632     Document Type: Article

References (40)

1. Aubry, L.; Bugi, A.; Lefort, N.; Rousseau, F.; Peschanski, M.; Perrier, A. L. Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. Proc. Natl. Acad. Sci. USA 105(43):16707-16712; 2008.
2. Bachoud-Levi, A. C.; Gaura, V.; Brugieres, P.; Lefaucheur, J. P.; Boisse, M. F.; Maison, P.; Baudic, S.; Ribeiro, M. J.; Bourdet, C.; Remy, P.; Cesaro, P.; Hantraye, P.; Peschanski, M. Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: A long-term follow-up study. Lancet Neurol. 5(4):303-309; 2006.
3. Bachoud-Levi, A. C.; Remy, P.; Nguyen, J. P.; Brugieres, P.; Lefaucheur, J. P.; Bourdet, C.; Baudic, S.; Gaura, V.; Maison, P.; Haddad, B.; Boisse, M. F.; Grandmougin, T.; Jeny, R.; Bartolomeo, P.; Dalla Barba, G.; Degos, J. D.; Lisovoski, F.; Ergis, A. M.; Pailhous, E.; Cesaro, P.; Hantraye, P.; Peschanski, M. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 356(9246):1975-1979; 2000.
4. Brederlau, A.; Correia, A. S.; Anisimov, S. V.; Elmi, M.; Paul, G.; Roybon, L.; Morizane, A.; Bergquist, F.; Riebe, I.; Nannmark, U.; Carta, M.; Hanse, E.; Takahashi, J.; Sasai, Y.; Funa, K.; Brundin, P.; Eriksson, P. S.; Li, J. Y. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: Effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 24(6):1433-1440; 2006.
5. Clarke, D. J.; Dunnett, S. B.; Isacson, O.; Bjorklund, A. Striatal grafts in the ibotenic acid-lesioned neostriatum: Ultrastructural and immunocytochemical studies. Prog. Brain Res. 78:47-53; 1988.
6. Clarke, D. J.; Dunnett, S. B.; Isacson, O.; Sirinathsinghji, D. J.; Bjorklund, A. Striatal grafts in rats with unilateral neostriatal lesions - I. Ultrastructural evidence of afferent synaptic inputs from the host nigrostriatal pathway. Neuroscience 24(3):791-801; 1988.
7. Costa, M.; Dottori, M.; Ng, E.; Hawes, S. M.; Sourris, K.; Jamshidi, P.; Pera, M. F.; Elefanty, A. G.; Stanley, E. G. The hESC line Envy expresses high levels of GFP in all differentiated progeny. Nat. Methods 2(4):259-260; 2005.
8. Dottori, M.; Pera, M. F. Neural differentiation of human embryonic stem cells. Methods Mol. Biol. 438:19-30; 2008.
9. Dunnett, S. B.; Isacson, O.; Sirinathsinghji, D. J.; Clarke, D. J.; Bjorklund, A. Striatal grafts in rats with unilateral neostriatal lesions - III. Recovery from dopamine-dependent motor asymmetry and deficits in skilled paw reaching. Neuroscience 24(3):813-820; 1988.
10. Dunnett, S. B.; Isacson, O.; Sirinathsinghji, D. J.; Clarke, D. J.; Bjorklund, A. Striatal grafts in the ibotenic acid-lesioned neostriatum: Functional studies. Prog. Brain Res. 78:39-45; 1988.
11. Dunnett, S. B.; Rosser, A. E. Cell transplantation for Huntington's disease Should we continue? Brain Res. Bull. 72(2-3):132-147; 2007.
12. Farrington, M.; Wreghitt, T. G.; Lever, A. M.; Dunnett, S. B.; Rosser, A. E.; Barker, R. A. Neural transplantation in Huntington's disease: The NEST-UK donor tissue microbiological screening program and review of the literature. Cell Transplant. 15(4):279-294; 2006.
13. Freeman, T. B.; Cicchetti, F.; Hauser, R. A.; Deacon, T. W.; Li, X. J.; Hersch, S. M.; Nauert, G. M.; Sanberg, P. R.; Kordower, J. H.; Saporta, S.; Isacson, O. Transplanted fetal striatum in Huntington's disease: Phenotypic development and lack of pathology. Proc. Natl. Acad. Sci. USA 97(25):13877-13882; 2000.
14. Freeman, T. B.; Hauser, R. A.; Willing, A. E.; Zigova, T.; Sanberg, P. R.; Saporta, S. Transplantation of human fetal striatal tissue in Huntington's disease: Rationale for clinical studies. Novartis Found. Symp. 231:129-147; 2000.
15. Furtado, S.; Sossi, V.; Hauser, R. A.; Samii, A.; Schulzer, M.; Murphy, C. B.; Freeman, T. B.; Stoessl, A. J. Positron emission tomography after fetal transplantation in Huntington's disease. Ann. Neurol. 58(2):331-337; 2005.
16. Gallina, P.; Paganini, M.; Lombardini, L.; Saccardi, R.; Marini, M.; De Cristofaro, M. T.; Pinzani, P.; Salvianti, F.; Crescioli, C.; Di Rita, A.; Bucciantini, S.; Mechi, C.; Sarchielli, E.; Moretti, M.; Piacentini, S.; Gritti, G.; Bosi, A.; Sorbi, S.; Orlandini, G.; Vannelli, G. B.; Di Lorenzo, N. Development of human striatal anlagen after transplantation in a patient with Huntington's disease. Exp. Neurol. 213:241-244; 2008.
17. Gaura, V.; Bachoud-Levi, A. C.; Ribeiro, M. J.; Nguyen, J. P.; Frouin, V.; Baudic, S.; Brugieres, P.; Mangin, J. F.; Boisse, M. F.; Palfi, S.; Cesaro, P.; Samson, Y.; Hantraye, P.; Peschanski, M.; Remy, P. Striatal neural grafting improves cortical metabolism in Huntington's disease patients. Brain 127(Pt. 1):65-72; 2004.
18. Hauser, R. A.; Furtado, S.; Cimino, C. R.; Delgado, H.; Eichler, S.; Schwartz, S.; Scott, D.; Nauert, G. M.; Soety, E.; Sossi, V.; Holt, D. A.; Sanberg, P. R.; Stoessl, A. J.; Freeman, T. B. Bilateral human fetal striatal transplantation in Huntington's disease. Neurology 58(5):687-695; 2002.
19. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72(6):971-983; 1993.
20. Isacson, O.; Dunnett, S. B.; Bjorklund, A. Graft-induced behavioral recovery in an animal model of Huntington disease. Proc. Natl. Acad. Sci. USA 83(8):2728-2732; 1986.
21. Itsykson, P.; Ilouz, N.; Turetsky, T.; Goldstein, R. S.; Pera, M. F.; Fishbein, I.; Segal, M.; Reubinoff, B. E. Derivation of neural precursors from human embryonic stem cells in the presence of noggin. Mol. Cell. Neurosci. 30(1):24-36; 2005.
22. Krystkowiak, P.; Gaura, V.; Labalette, M.; Rialland, A.; Remy, P.; Peschanski, M.; Bachoud-Levi, A. C. Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease. PLoS ONE 2(1):e166; 2007.
23. Nakao, N.; Itakura, T. Fetal tissue transplants in animal models of Huntington's disease: The effects on damaged neuronal circuitry and behavioral deficits. Prog. Neurobiol. 61(3):313-338; 2000.
24. Palfi, S.; Conde, F.; Riche, D.; Brouillet, E.; Dautry, C.; Mittoux, V.; Chibois, A.; Peschanski, M.; Hantraye, P. Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease. Nat. Med. 4(8):963-966; 1998.
25. Park, C. H.; Minn, Y. K.; Lee, J. Y.; Choi, D. H.; Chang, M. Y.; Shim, J. W.; Ko, J. Y.; Koh, H. C.; Kang, M. J.; Kang, J. S.; Rhie, D. J.; Lee, Y. S.; Son, H.; Moon, S. Y.; Kim, K. S.; Lee, S. H. In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons. J. Neurochem. 92(5):1265-1276; 2005.
26. Pera, M. F.; Andrade, J.; Houssami, S.; Reubinoff, B.; Trounson, A.; Stanley, E. G.; Ward-van Oostwaard, D.; Mummery, C. Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin. J. Cell Sci. 117(Pt. 7):1269-1280; 2004.
27. Perrier, A. L.; Tabar, V.; Barberi, T.; Rubio, M. E.; Bruses, J.; Topf, N.; Harrison, N. L.; Studer, L. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 101(34):12543-12548; 2004.
28. Pritzel, M.; Isacson, O.; Brundin, P.; Wiklund, L.; Bjorklund, A. Afferent and efferent connections of striatal grafts implanted into the ibotenic acid lesioned neostriatum in adult rats. Exp. Brain Res. 65(1):112-126; 1986.
29. Ramaswamy, S.; Shannon, K. M.; Kordower, J. H. Huntington's disease: Pathological mechanisms and therapeutic strategies. Cell Transplant. 16(3):301-312; 2007.
30. Reubinoff, B. E.; Itsykson, P.; Turetsky, T.; Pera, M. F.; Reinhartz, E.; Itzik, A.; Ben-Hur, T. Neural progenitors from human embryonic stem cells. Nat. Biotechnol. 19(12):1134-1140; 2001.
31. Reuter, I.; Tai, Y. F.; Pavese, N.; Chaudhuri, K. R.; Mason, S.; Polkey, C. E.; Clough, C.; Brooks, D. J.; Barker, R. A.; Piccini, P. Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease. J. Neurol. Neurosurg. Psychiatry 79(8):948-951; 2008.
32. Rosser, A. E.; Barker, R. A.; Harrower, T.; Watts, C.; Farrington, M.; Ho, A. K.; Burnstein, R. M.; Menon, D. K.; Gillard, J. H.; Pickard, J.; Dunnett, S. B. Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. J. Neurol. Neurosurg. Psychiatry 73(6):678-685; 2002.
33. Rosser, A. E.; Dunnett, S. B. Neural transplantation in patients with Huntington's disease. CNS Drugs 17(12):853-867; 2003.
34. Schulz, T. C.; Noggle, S. A.; Palmarini, G. M.; Weiler, D. A.; Lyons, I. G.; Pensa, K. A.; Meedeniya, A. C.; Davidson, B. P.; Lambert, N. A.; Condie, B. G. Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Stem Cells 22(7):1218-1238; 2004.
35. Shufaro, Y.; Reubinoff, B. E. Therapeutic applications of embryonic stem cells. Best Pract. Res. Clin. Obstet. Gynaecol. 18(6):909-927; 2004.
36. Sirinathsinghji, D. J.; Dunnett, S. B.; Isacson, O.; Clarke, D. J.; Kendrick, K.; Bjorklund, A. Striatal grafts in rats with unilateral neostriatal lesions - II. In vivo monitoring of GABA release in globus pallidus and substantia nigra. Neuroscience 24(3):803-811; 1988.
37. Song, J.; Lee, S. T.; Kang, W.; Park, J. E.; Chu, K.; Lee, S. E.; Hwang, T.; Chung, H.; Kim, M. Human embryonic stem cell-derived neural precursor transplants attenuate apomorphine-induced rotational behavior in rats with unilateral quinolinic acid lesions. Neurosci. Lett. 423(1):58-61; 2007.
38. Sonntag, K. C.; Pruszak, J.; Yoshizaki, T.; van Arensbergen, J.; Sanchez-Pernaute, R.; Isacson, O. Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells 25(2):411-418; 2007.
39. Vazey, E. M.; Chen, K.; Hughes, S. M.; Connor, B. Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease. Exp. Neurol. 199(2):384-396; 2006.
40. Zietlow, R.; Lane, E. L.; Dunnett, S. B.; Rosser, A. E. Human stem cells for CNS repair. Cell Tissue Res. 331(1):301-322; 2008.